Patricia Díez

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial

Peter Hoskin, Amy A. Kirkwood, Bilyana Popova et al. · The Lancet Oncology · 2014 · 238 citations

Lymphoid Neoplasia, Surgical Oncology, Radiation Therapy +6

UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy

Patricia Díez, Gerard G. Hanna, K. Aitken et al. · Clinical Oncology · 2022 · 117 citations

Radiation Medicine, Uk 2022, Medical Imaging +10

Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial

Mary McCormack, Gemma Eminowicz, Dolores Gallardo et al. · The Lancet · 2024 · 109 citations · Full text

Advanced Cervical Cancer, Cervical Cancer Management, Cervical Cancer +10

Recommendations for the Use of Radiotherapy in Nodal Lymphoma

Peter Hoskin, Patricia Díez, M.V. Williams et al. · Clinical Oncology · 2012 · 62 citations

Adaptive Radiotherapy, Nodal Lymphoma, Radiation Therapy +4

LBA8 A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE trial

Mary McCormack, D. Gallardo Rincón, Gemma Eminowicz et al. · Annals of Oncology · 2023 · 62 citations · Full text

Advanced Cervical Cancer, Cervical Cancer, Radiation Therapy +8